Item 5.07 Submission of Matters to a Vote of Security Holders.

On September 21, 2022, Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the "Company"), held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). The final voting results for the proposals submitted to a vote of the Company's stockholders at the Annual Meeting are as follows:

Proposal 1: Election of five directors to the Board of Directors of the Company to hold office until the Company's 2023 Annual Meeting of Stockholders or until their respective successors are elected and qualified:



                       Votes        Votes       Broker
     Director           For       Withheld    Non-Votes
Charles Cherington   24,960,908   3,213,277   14,849,874
  Matthew Angel      26,060,381   2,113,804   14,849,874
Nicholas J. Singer   26,037,962   2,136,223   14,849,874
  Gregory Fiore      25,923,220   2,250,965   14,849,874
  William Wexler     26,044,952   2,129,233   14,849,874

Proposal 2: Approval of a non-binding advisory resolution approving the compensation of the Company's named executive officers as disclosed in the Company's 2022 Proxy Statement for the Annual Meeting:



   Votes        Votes                     Broker
    For        Against    Abstentions   Non-Votes
 23,660,694   4,462,421     51,070      14,849,874

Proposal 3: Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the 2022 fiscal year:



  Votes       Votes                   Broker
   For       Against   Abstentions   Non-Votes
42,584,506   373,779     65,774          -

Proposal 4: Approval of the amendment to the Company's Restated Certificate of Incorporation, as amended, to effect a reverse stock split (the "Reverse Stock Split") with respect to the Company's issued and outstanding common stock, par value $0.005 per share, at a ratio of 1-for-10 to 1-for-20 (the "Range"), with the ratio at which the Reverse Stock Split would be effected to be a ratio within the Range to be determined at the discretion of the Company's Board of Directors:



  Votes        Votes                    Broker
   For        Against    Abstentions   Non-Votes
40,383,795   2,603,310     36,954          -

No other matters were considered or voted upon at the Annual Meeting.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses